Advanced Filters
noise

insomnia Clinical Trials

A listing of insomnia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 211 clinical trials
S Scott E Krahl, PhD MA BA

Treatments for Insomnia in Veterans With PTSD

This randomized trial will compare a novel treatment, Acceptance of the Behavioral Changes to Treat Insomnia (ABC-I) to Cognitive Behavioral Therapy for Insomnia (CBT-I) among Veterans with comorbid Post-Traumatic Stress Disorder (PTSD) and insomnia disorder. ABC-I combines the behavioral components of CBT-I with components of another behavioral therapy (Acceptance and …

18 years of age All Phase N/A
N NGAN YIN CHAN, PhD

Prevention of Insomnia in At-risk Youth

This study aims to conduct a randomized controlled trial in comparing cognitive behavioral insomnia prevention program with the active control group in youths who are at risk of insomnia. The results of this study will allow us to take this potential efficacious prevention program to scale and reduce the associated …

15 - 24 years of age All Phase N/A
R Renata Bonaldi, PhD

SleepUp Digital CBTi-based Platform for Insomnia

Cognitive-Behavioral Therapy for insomnia (CBTi) is a well-established therapeutic intervention for insomnia. SleepUp provides a digital therapeutics platform based on CBTi and additional features. This clinical trial aims at analyzing the efficacy of the CBTi-based platform offered by SleepUp in reducing symptoms of insomnia and will be conducted in 2 …

20 - 60 years of age All Phase N/A
M Marcus Ng, MD

Lemborexant Treatment of Insomnia Linked to Epilepsy

The goal of this clinical trial is to assess whether Lemborexant can improve sleep in patients with epilepsy.

18 years of age All Phase 3
D Denise B Naylor, PhD

Pimavanserin for Insomnia in Veterans With PTSD

This is a preliminary randomized, double-blind, placebo-controlled trial comparing pimavanserin 34mg at bedtime vs. placebo for the treatment of insomnia associated with post-traumatic stress disorder.

18 - 64 years of age All Phase 2
P Pei-Shan Tsai, PhD

Digital Sleep Program for College Students with Insomnia

This randomized controlled trial (RCT) study aims to evaluate the effectiveness of a digital-based multimodal sleep management program compared to a waitlist control group in improving sleep-related outcomes, including insomnia severity, daytime sleepiness, objective sleep parameters, and sleep reactivity to stress, as well as psychological health indices, such as depression, …

18 - 26 years of age All Phase N/A
K Kristi E Pruiksma, PhD

Behavioral Insomnia Treatment in Mild Traumatic Brain Injury

This is a single site, two-armed random controlled trials (RCT) comparing six sessions of Cognitive Behavioral Therapy for Insomnia (CBT-I) with four sessions of Brief Behavioral Therapy for Insomnia (BBT-I) in service members with comorbid insomnia and prolonged postconcussive symptoms present for at least 3 months after Mild Traumatic Brain …

18 - 45 years of age All Phase N/A
M Michael K Ong, MD PhD

Treatments in Women Veterans With Insomnia and PTSD

This pilot trial will compare trauma-informed Cognitive Behavioral Therapy for Insomnia (CBT-I) to a psychoeducational intervention in women Veterans with comorbid insomnia and posttraumatic stress disorder (PTSD). The CBT-I intervention includes trauma-informed adaptations to an insomnia treatment and the psychoeducational intervention is modeled after usual care in a VA Women's …

18 years of age Female Phase N/A
S Soohyun Nam, PhD, APRN, ANP-BC, FAHA, FAAN

Project Women's Insomnia Sleep Health Equity Study (WISHES)

The purpose of this study is to achieve health and healthcare equity by implementing an equity-focused, mindfulness-based sleep intervention to reduce stress and sleep deficiency-related cardiometabolic disease burden in Black women.

18 - 70 years of age Female Phase N/A
A Anja Lia

Cognitive Behavioural Therapy for Insomnia in Patients With Coronary Heart Disease

Insomnia is prevalent (45%) in CHD patients and associated with significantly increased risk for recurrent cardiovascular events. Insomnia has recently been identified as the third most important risk factor for prognosis. However, very few insomnia patients are identified and receive treatment of insomnia today. CBT-I is the first-line treatment for …

18 - 75 years of age All Phase N/A

Simplify language using AI